Biotechnology - Lexington, Massachusetts, United States
Excelimmune, Inc. is a biopharmaceutical company specializing in the discovery and development of Antibody Combination Therapeutics (ACT) for the treatment of complex diseases. Using its patented ACT expression technology and proprietary human antibody discovery engine, Excelimmune is uniquely poised to address the complexity of infectious disease, cancer and inflammation, which present the common challenge of resistance to single mechanism therapies.
Apache
WordPress.org
Google Font API
Mobile Friendly